Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
NYMXF Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: May 05, 2025
Report Source: 2024 3rd Quarter Report
Nymox Pharmaceutical Corp. Stock Analysis NYMXF
United States Health Care Nano Cap Report: Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. The company is headquartered in Saint-Laurent, Quebec. The firm is focused on developing its drug candidate, Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The firm also has a patent portfolio covering its marketed products, its investigational drugs, as well as other therapeutic and diagnostic indications. The company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer’s disease. Its products also include NicAlert and TobacAlert. NicAlert is a simple test to determine smoking status. The company is an easy-to-read test strip that can be used with either a saliva or a urine sample. TobacAlert is a home test that provides a quick, accurate, on-the-spot determination of a person’s level of exposure to tobacco products, including second-hand smoke.
Read More Nymox Pharmaceutical Corp (NYMXF) Chart
Key Statistics of Nymox Pharmaceutical Corp (NYMXF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.11Volume
13.63KP/E Ratio (TTM)
-52 Week Range
Market Cap
12.53MAvg. Volume
74.98KDividend Yield
-Financial Metrics & Statements of Nymox Pharmaceutical Corp (NYMXF)
FAQ's for Nymox Pharmaceutical Corp (NYMXF)
- According to Musaffa’s Shariah screening methodology, Nymox Pharmaceutical Corp (NYMXF) is currently classified as NOT HALAL as of May 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nymox Pharmaceutical Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nymox Pharmaceutical Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nymox Pharmaceutical Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nymox Pharmaceutical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nymox Pharmaceutical Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.